TLR8 agonist 4

• Target:

  HBV|||Others

• Related Pathways:

  Others|||Microbiology/Virology

• Bioactivity:

  TLR8 agonist 4 was effective in inhibiting both wild-type and drug-resistant (lamivudine and entecavir) HBV strains with their IC50 values of 0.15 and 0.10 ?M, respectively.

• Molecular Formula:

  C28H27N5O5S

• Molecular Weight:

  545.61

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C